查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1137697

实验室自动化软件市场 - 增长、趋势、COVID-19 影响和预测（2022-2027 年）

Lab Automation Software Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 124 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期间（2022-2027 年），实验室自动化软件市场预计将以 8.15% 的复合年增长率增长。

主要亮点

  • 自动化用于从蛋白质组学到系统生物学的各种生命科学应用。通过使用软件对专用工作站和仪器进行编程，自动化常规实验室程序，助理科学家和工程师可以创造性地了解他们的实验的含义，而不是把他们的时间花在乏味、重复的任务上。您将能够思考和设计有用的后续行动项目或开发替代方法。
  • 机器人技术与自动化的集成正在迅速增加，以提高生产力并降低实验室运营成本。预计在预测期内将促进市场的增长。了解和发现生命本质的进展，例如聚合□炼式反应 (PCR)、剪接基因和测序手段，正在兴起，并可能推动市场增长。
  • 此外，专家们认为自动化是临床试验数量呈指数增长的关键解决方案。数字化和自动化使科学家能够自动化整个过程，从而减少污染、数字数据记录和更快的数据处理。这大大减少了每次测试所需的时间。
  • 自动化在帮助实验室最大限度地提高效率、简化操作、建立可扩展且可持续的方法以及最大限度地减少对服务和患者负责的服务的干扰方面发挥着关键作用然而，COVID-19 大流行的影响加剧了实验室面临的许多现有挑战，包括人员短缺、TAT 改善和诊断测试错误减少。
  • 设置实验室自动化模块（包括软件）的成本偏高，令小型企业望而却步。预计这一因素将阻碍预测期内的市场增长。

主要市场趋势

实验室信息管理系统有望占据最大市场份额

  • 实验室信息管理系统行业在过去五年中经历了强劲增长，因为实验室对不断增加的样本量做出了反应，部分原因是人口老龄化导致对诊断测试的需求增加。
  • 特别是，我们专注于开发软件来解决业务问题，例如数据安全和合规性。该市场受到监管合规压力增加、医疗保健系统集成需求增加、从遗留系统向商业 LIMS 解决方案迁移以及 LIMS 产品技术进步等因素的推动。
  • 此外，对基因组和 DNA 等测试的资助增加了实验室信息和数据。因此，基因组研究的兴起对市场的增长产生了积极影响。高精度和消除手动数据转录错误等好处也有望推动市场发展。
  • 根据美国国立卫生研究院 (NIH) 的数据，2021 年来自 NIH 的人类基因组资助预计约为 44.3 亿美元，2022 年将达到 45.5 亿美元。预计将推动市场增长。
  • 北爱尔兰卫生部长最近宣布推出耗资 4000 万英镑的新实验室信息管理系统 (LIMS)，该系统将显着改善医疗保健关键领域的临床诊断服务交付。

预计亚太地区将成为增长最快的市场

  • 由于製药市场的快速增长，亚太地区是实验室自动化软件增长最快的地区。该地区的增长归因于对药物研发的投资增加。
  • 例如，2022 年 5 月，美国製药公司辉瑞 (Pfizer) 在印度的印度理工学院马德拉斯研究园建立了亚洲首个全球药物开发中心。该公司将在该中心投资 2000 万美元，用于开发创新配方、小分子和活性药物成分 (API)。
  • 2022年2月，澳大利亚生物製药公司维罗尼集团签署合同，在中国珠海国家高新技术产业开发区建设新的研发中心。这些扩张举措和投资预计将促进该地区的市场增长。
  • 此外，与其他大陆不同，该地区拥有许多异质的人口群体，非常适合进行药物研究。由于拥有熟练的劳动力和药物开发的低成本，该地区被认为是外包药物研究的首选目的地。
  • 此外，其他地区的公司面临严格的法规和漫长的工期，进一步增加了项目成本。因此，北美公司正在转向与 CRO（合同研究组织）合作，该地区因赢得更多研究项目而受益最大。时间和预算是开发中最关键的因素，这就是製药公司选择自动化实验室软件的原因，这些软件可以减少与药物发现相关的错误、成本和时间。
  • 例如，2021 年 10 月，韩国临床诊断公司 GC Labs 推出了韩国首个微生物学全实验室自动化系统 WASPLab。该解决方案可自动处理以前的样本接收、接种、孵化和解释等手动步骤。特别是，文化会自动确定为正面或负面。此外，检查者可以查看监视器上的图像并将最终结果报告给临床专家。

竞争格局

实验室自动化软件市场的竞争不激烈，参与者数量也不多。更新的技术也正在出现，以自动化常规实验室流程，例如测试和筛选。自动化工具可以实时处理并发请求，显着提高生产力和吞吐量。

  • 2022 年 3 月 - 由 Y Combinator 支持的生命科学实验室信息化初创公司 Scispot 推出了 Labsheets，以帮助摆脱不科学的电子表格和过时的研究信息管理系统。已宣布。 Labsheets 是一种无代码的关係数据库产品，专门设计用于支持生命科学实验室的数据管理、样本跟踪、审计跟踪、自动报告和集成要求。 Scispot 的 Labsheets 目标是减少生命科学实验室在电子表格中管理数据所花费的时间，让实验室专业人员能够设计和自动化工作流程，从而更快地将科学突破推向市场。这样做是为了加强生命科学实验室。
  • 2021 年 9 月 - Veeva Vault LIMS 是 Veeva Systems 的全新云应用程序，旨在实现质量控制 (QC) 实验室运营的现代化。通过将 Vault LIMS 整合到 Veeva Vault 质量套件中，製造商将能够将其实验室运营与更广泛的质量生态系统无缝连接。这简化了样品管理、测试执行和实验室研究流程，以加快批次发布并降低库存成本。
  • 2021 年 7 月 - LabVantage Solutions, Inc 推出了其旗舰产品 LabVantage LIMS 的 8.7 版，旨在为外部实验室客户提供安全的自助式门户网站。升级后的 LabVantage LIMS 8.7 允许客户保护有价值和敏感的数据，同时通过门户在实验室外扩展适当的访问权限，无需手动请求测试和其他服务。
  • 2021 年 7 月 - 分析实验室 LIMS 软件提供商 Promium, L.L.C. 宣布推出新版本的 Element LIMS 实验软件。 Element LIMS 是一个全面的实验室信息管理系统，可管理整个实验室的分析和运营活动。 Element LIMS 版本 7 包括增强功能、重新设计的用户界面和新的开发框架，所有这些都旨在显着提高实验室性能和合规性。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法

第 3 章执行摘要

第 4 章市场洞察

  • 市场概览
  • 工业吸引力 - 波特五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 工业价值链分析
  • 评估 COVID-19 对市场的影响

第5章市场动态

  • 市场驱动力
    • 製药和生物技术公司的研发活动增加
    • 药物发现和基因组学的需求增加
  • 市场製约因素
    • 初始设置成本很高，而且整个模块可能很昂贵

第 6 章市场细分

  • 通过软件
    • 实验室信息管理系统 (LIMS)
    • 实验室信息系统 (LIS)
    • 色谱数据系统 (CDS)
    • 电子实验室笔记本 (ELN)
    • 科学数据管理系统 (SDMS)
  • 按应用领域
    • 药物发现
    • 基因组学
    • 蛋白质组学
    • 临床诊断
    • 其他应用领域
  • 地区信息
    • 北美
    • 欧洲
    • 亚太地区
    • 世界其他地区

第 7 章竞争格局

  • 公司简介
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Hudson Robotics
    • Becton, Dickinson & Company
    • Synchron Lab Automation
    • Agilent Technologies
    • Siemens Healthineers AG
    • Tecan Group Ltd
    • Perkinelmer Inc.
    • Bio-Rad Laboratories Inc.
    • Roche Holding AG
    • Eppendorf AG
    • Shimadzu Corporation

第8章 投资分析

第9章 市场机会与将来动向

简介目录
Product Code: 54877

The Lab Automation Software Market is expected to grow at a CAGR of 8.15% during the forecast period (2022 to 2027).

Key Highlights

  • Automation is used in various life science applications, from proteomics to systems biology. Automating routine laboratory procedures for using dedicated workstations and software to program instruments allows associate scientists and technicians to think creatively about the implications of their experimentation and to design useful follow-up projects or develop alternative approaches to their work instead of spending their days performing tasks with tedious repetition.
  • The integration of robotics and automation is rapidly increasing, owing to enhanced productivity and mitigated laboratory operational costs. It is likely to boost market growth over the forecast period. The progress in understanding and the discovery of the nature of life, including the polymerase chain reaction (PCR), splice genes, and means of sequencing, are on the rise, which may propel the market growth.
  • Additionally, the experts have credited automation as a crucial solution for the rapid increase in the number of clinical trials. With digitalization and automation, scientists were able to automate the whole process, which resulted in fewer contaminations, digital data recording, and faster processing of the data. This reduced the time taken by each trial significantly.
  • Automation plays a key role in helping laboratories maximize efficiency, simplify operations and establish a scalable and sustainable approach to minimize disruption to the services they provide and the patients they serve. However, The impact of the COVID-19 pandemic worsened many of the existing challenges labs face with staffing shortages, improving TAT, and reducing diagnostic testing errors.
  • The cost to set lab automation modules, including software, is on the higher side and discourages small enterprises. This factor is expected to hamper the market growth over the forecast period.

Key Market Trends

Laboratory Information Management System Expected to Have Largest Market Share

  • The laboratory information management system industry exhibited robust growth over the past five years as laboratories grappled with an increase in sample volumes, partly due to the increased demand for diagnostic testing from the burgeoning elderly population.
  • Industry operators have particularly focused on developing software that assists with operational issues, such as data security and regulatory compliance. This market is driven by certain factors, such as the rising pressure to comply with regulations, a growing need to integrate healthcare systems, a shift from legacy systems to commercial off-the-shelf LIMS solutions, and technological advancements in LIMS products.
  • Moreover, the funding for tests, such as genome and DNA, has led to an increase in laboratory information and data. Therefore, the rising practice of genome study is favoring the market growth. Associated advantages, such as high precision and elimination of manual data transcription errors, are also anticipated to provide a boost to the market.
  • According to NIH (National Institutes for Health), Human genome funding by the NIH was around 4.43 billion U.S. dollars in 2021, which is estimated at 4.55 billion U.S. dollars in 2022. such funding is also anticipated to boost the market.
  • Northern Ireland's Minister of Health recently announced the launch of a new GBP 40 million Laboratory Information Management System (LIMS) that will significantly improve the delivery of clinical diagnostic services in key areas of healthcare.

Asia Pacific is Expected to be the Fastest Growing Market

  • Asia-Pacific is the fastest-growing region for lab automation software, owing to the rapid growth in the pharmaceuticals market in this region. The growth can be attributed to the increased investment in pharmaceutical research and development in this region.​
  • For instance, in May 2022, US pharmaceutical company Pfizer set up its first global drug development center in Asia at the Indian Institute of Technology-Madras Research Park, India. The company has invested USD 20 million in the center to develop innovative formulations, small molecules, and active pharmaceutical ingredients (APIs).
  • Also, in February 2022, Beroni Group, an Australia-based biopharmaceutical company, signed a contract to build a new R&D center in China's Zhuhai National High-Tech Industrial Development Zone. These expansion initiatives and investments are expected to boost the market growth in the region.​
  • Furthermore, this region is ideal for conducting pharmaceutical research due to the large pool of heterogeneous population groups, unlike other continents. This region is considered the most preferred to outsource pharmaceutical research, owing to the availability of skilled labor and lower cost required to develop drugs. ​
  • Additionally, the companies in the other regions face stringent regulations and lengthy timelines, further escalating the project cost. Therefore, North American companies are shifting toward CRO (contract research organization) partnership, which has benefited this region the most to get more research projects. As time and the budget are the most crucial factors for the development, drug companies are opting for automated lab software that can reduce the errors, cost, and time-related to the discovery of the drug.​
  • For instance, in October 2021, GC Labs, a Korea-based clinical diagnostics company, introduced WASPLab, the first microbiology Total Laboratory Automation system in Korea. The solution automatically processes the steps from sample receipt to inoculation, culture, and interpretation, which had previously been conducted manually. In particular, it automatically interprets the culture as positive or negative. It allows test staff to double-check images on the monitor before reporting the final results to clinical professionals.

Competitive Landscape

The Lab Automation Software Market is neither highly competitive nor does it have a limited number of players. There are other newer technologies in the pipeline through which routine laboratory processes, such as testing and screening, are automated. Automation tools can process concurrent requests in real time, showing marked improvement in productivity and throughput.

  • March 2022 - Scispot, a Y Combinator-backed life science lab informatics startup, introduces Labsheets to assist life science labs in moving beyond non-scientific spreadsheets and outdated lab information management systems. Labsheets is a no-code relational database product explicitly designed for life science labs to support their data management, sample tracking, audit trail, automated report creation, and integration requirements. Scispot's goal with Labsheets is to empower life science labs by reducing the time they spend managing data in spreadsheets, allowing lab professionals to design and automate workflows and bring scientific breakthroughs to market faster.
  • September 2021 - Veeva Vault LIMS is a new cloud application from Veeva Systems designed to modernize quality control (QC) lab operations. By incorporating Vault LIMS into Veeva Vault Quality Suite, manufacturing organizations can seamlessly connect their lab operations with the broader quality ecosystem. This will speed up the batch release and lower inventory costs by streamlining sample management, test execution, and lab investigation processes.
  • July 2021 - LabVantage Solutions, Inc has launched the 8.7 edition of its flagship LabVantage LIMS designed to provide a secure self-service web portal for the lab's external clients. With the upgraded LabVantage LIMS 8.7, customers can extend appropriate access rights outside the laboratory via the Portal while protecting their valuable and sensitive data, eschewing the need for manual requests for tests and other services.
  • July 2021 - Promium, L.L.C., a provider of LIMS software for analytical testing laboratories, launched a new version of Element LIMS laboratory software. A comprehensive laboratory information management system, Element LIMS manages analytical and operational activities across the laboratory. Element LIMS version 7 includes feature enhancements, a redesigned user interface, and a new development framework, all targeted to increase laboratory performance and compliance significantly.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the COVID-19 Impact on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Research and Development by Pharmaceutical and Biotech Companies
    • 5.1.2 Growing Demand from Drug Discovery and Genomics
  • 5.2 Market Restraints
    • 5.2.1 Higher Initial Setup Costs Can be Expensive for Overall Module

6 MARKET SEGMENTATION

  • 6.1 By Software
    • 6.1.1 Laboratory Information Management System (LIMS)
    • 6.1.2 Laboratory Information System (LIS)
    • 6.1.3 Chromatography Data System (CDS)
    • 6.1.4 Electronic Lab Notebook (ELN)
    • 6.1.5 Scientific Data Management System (SDMS)
  • 6.2 By Field of Application
    • 6.2.1 Drug Discovery
    • 6.2.2 Genomics
    • 6.2.3 Proteomics
    • 6.2.4 Clinical Diagnostics
    • 6.2.5 Other Applications
  • 6.3 By Geography
    • 6.3.1 North America
    • 6.3.2 Europe
    • 6.3.3 Asia Pacific
    • 6.3.4 Rest of the world

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Thermo Fisher Scientific
    • 7.1.2 Danaher Corporation
    • 7.1.3 Hudson Robotics
    • 7.1.4 Becton, Dickinson & Company
    • 7.1.5 Synchron Lab Automation
    • 7.1.6 Agilent Technologies
    • 7.1.7 Siemens Healthineers AG
    • 7.1.8 Tecan Group Ltd
    • 7.1.9 Perkinelmer Inc.
    • 7.1.10 Bio-Rad Laboratories Inc.
    • 7.1.11 Roche Holding AG
    • 7.1.12 Eppendorf AG
    • 7.1.13 Shimadzu Corporation

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS